Joanne Van Zuidam
Editor

Joanne Van Zuidam is the editor of Drug Discovery & Development. An experienced health editor, she previously served as editor of Optometric Office magazine, a publication highlighting new products and technology for eye care professionals. As a freelance writer, she has written extensively on a broad range of health and wellness topics for numerous national magazines and websites. 

A meta-analysis of more than 3.4 million Swedes aged 40 to 80 found an association between owning a dog and living longer.
11.17.2017
11:35am
A Q&A with Dr. Geert Cauwenbergh, President and CEO, RXi Pharmaceticals
11.16.2017
10:39am
Cancer researchers at the University of Bergen (UiB) in Norway have discovered that a medication prescribed for parasites, such as tapeworms and giardia,...
11.15.2017
11:43am
Will fructan-free be the next food trend? If a new study holds true, fructan, a carbohydrate found in wheat, will replace gluten as the guilty party in causing...
11.14.2017
11:08am
An exclusive interview with Jim Carroll, VP of Real World Evidence at ICON
11.10.2017
8:00am
Advertisement
The U.S. Food and Drug Administration (FDA) expanded the approval of the Roche drug vemurafenib (Zelboraf) to include the treatment of certain adult patients...
11.7.2017
9:22am
The lipids that harden and clog the arteries (atherosclerosis) may not come from food, but rather bacteria found in the mouth. That’s according to researchers...
11.3.2017
11:27am
The immune-oncology focused biotechnology company's cancer vaccine, BriaVax, has demonstrated encouraging clinical results, and is intent on building upon...
11.1.2017
10:30am
A research team from Carnegie Mellon University and the University of Pittsburgh have developed an innovative way to identify suicidal individuals—with the...
10.31.2017
12:01pm
The U.S. Food & Drug Administration (FDA) proposed a new rule to revoke a health claim for soy protein and heart disease.
10.30.2017
12:02pm
First FDA-Approved Treatment in More Than 60 Years for Patients with gMG, a Chronic and Debilitating Neuromuscular Disorder.
10.27.2017
11:45am
Kite Pharma’s Yescarta, a chimeric antigen receptor (CAR) T cell therapy, is the second gene therapy approved by the FDA and the first for certain types of non...
10.19.2017
11:39am
The U.S. Food and Drug Administration’s Cellular, Tissue and Gene Therapies Advisory Committee yesterday endorsed the first gene therapy for patients with...
10.13.2017
12:17pm
Advertisement
The National Brain Tumor Society Clinical Trial Finder was designed specifically for brain tumor patients by a volunteer web developer who, himself, has...
10.13.2017
10:11am
The U.S. Food and Drug Administration has approved a new treatment option for patients who have moderate to severe central sleep apnea.
10.9.2017
11:37am
New research finds vitamin D supplementation, in addition to standard asthma medication, could halve the risk of acute exacerbations which require...
10.4.2017
11:24am
A new study, published in the Journal of the American College of Cardiology, has found an association between skipping breakfast and atherosclerosis.
10.3.2017
11:25am
A Q&A with Bob Miglani of Applied DNA Sciences about how the company’s plant-based SigNature DNA technology can assist the pharmaceutical industry in...
9.28.2017
8:41am
The American Association of Cancer Research recently released its 2017 Cancer Progress Report. Here are the highlights of nine newly approved cancer drugs—two...
9.25.2017
11:15am
Both low and high levels of magnesium in the blood increased risk of dementia by 30 percent.
9.22.2017
11:18am
A Q&A with Art Levin, Ph.D. on the evolution of RNA therapeutics and a new technology that’s driving drug discovery for rare inherited diseases.
9.22.2017
10:07am
Advertisement
In Phase III HALO studies in chronic and episodic migraine, the monoclonal antibody fremanezumab met all 25 pre-specified study endpoints across both monthly...
9.21.2017
11:46am
The European Society for Medical Oncology (ESMO) is wrapping up. About 24,000 people from 131 countries attended the congress this year. With a record number...
9.12.2017
12:33pm
New research from Queens University Belfast has revealed that aspirin could reverse the effects of tooth decay.
9.11.2017
11:38am
A new study from Boston’s Children’s Hospital has discovered a genetic mutation that triggers a disease linked to vampire folklore.
9.8.2017
1:53pm
While the variants in this recessive gene has been linked to higher incidence of skin cancer, researchers have not been able to determine if the variants in...
9.7.2017
12:21pm
New results from the ALEX trial, along with data from the Phase III ALUR trial, will be presented at the European Society for Medical Oncology (ESMO) congress...
9.6.2017
11:41am
Adipose tissue may influence the development of cancer in diverse ways, depending on the type of fat and the location in the body.
9.1.2017
11:59am
The trial will evaluate a formulation of ropinirole delivered via Titan's proprietary ProNeura continuous, long-term drug delivery platform.
8.31.2017
11:19am
The historic action makes Novartis Pharmaceutical’s CAR-T cell treatment the first gene therapy available in the United States, and according to the FDA,...
8.30.2017
12:02pm
More good news for chocolate lovers. Italian researchers have found dark chocolate enriched with extra virgin olive oil was associated with an improved...
8.30.2017
10:25am
A comparison of two different fitness routines shows that both can have an anti-aging effect on the brain in the elderly, but only dancing provides a...
8.29.2017
11:26am
About 25 percent of heart attack patients will experience another cardiovascular event within five years, even if they do not have high cholesterol....
8.28.2017
11:54am
A report released by the Cleveland Clinic last month shared some disappointing news. Its second assessment of the Alzheimer drug pipeline revealed a slow...
8.23.2017
10:47am
Drug Discovery & Development spoke to Joseph Murphy, Ph.D., director of science, R&D at Charles River Laboratories about using NSAIDs as an effective...
8.22.2017
11:49am
The head-to-head comparison pitted Novo Nordisk’s semaglutide against Eli Lilly’s dulaglutide (Trulicity). The SUSTAIN 7 trial results demonstrated that people...
8.17.2017
10:40am
Harvard researchers analyzed more than 2,000 skeletons from cadaveric and archaeological collections across the United States and found that not only has the...
8.15.2017
11:45am
Researchers at Johns Hopkins University found that prehypertension— elevated blood pressure that is not high enough to categorize as high blood pressure, yet...
8.14.2017
10:37am
The study, published in Science Translational Medicine, not only showed immunotherapy to be safe for those diagnosed with type I diabetes, but also that it...
8.10.2017
12:23pm